Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: Comparative cohort study

British Journal of Psychiatry

Volumn 199, Issue 2, 2011, Pages 140-144

  Harrison Woolrych, Mira ^a   Skegg, Keren ^b   Ashton, Janelle ^b   Herbison, Peter ^b   Skegg, David C G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Department of Psychological Medicine ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ANXIETY DISORDER; ARTICLE; AUTISM; BIPOLAR DISORDER; COHORT ANALYSIS; CONDUCT DISORDER; CONTROLLED STUDY; DELUSIONAL DISORDER; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DEFICIENCY; MOOD DISORDER; NOCTURNAL ENURESIS; OBSERVATIONAL STUDY; OBSESSIVE COMPULSIVE DISORDER; ORGANIC BRAIN SYNDROME; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PUERPERAL PSYCHOSIS; QUESTIONNAIRE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELF REPORT; SLEEP DISORDER; SOMATOFORM DISORDER; TARDIVE DYSKINESIA; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHILD; CLOZAPINE; COHORT STUDIES; DIBENZOTHIAZEPINES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW ZEALAND; NOCTURNAL ENURESIS; PRODUCT SURVEILLANCE, POSTMARKETING; RISPERIDONE; URBAN POPULATION; YOUNG ADULT;

EID: 79961010383     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.110.087478     Document Type: Article

References (25)

1. Frankenburg F, Kando JC, Centorrino F, Gilbert J. Bladder dysfunction associated with clozapine therapy. J Clin Psychiatry 1996; 57: 39-40. (Pubitemid 26030528)
2. Praharaj SK, Arora M. Amitryptyline for clozapine-induced nocturnal enuresis and sialorrhoea. Br J Clin Pharmacol 2006; 63: 128-9.
3. Lee MJ, Kim CE. Use of aripiprazole in clozapine induced enuresis: report of two cases. J Korean Med Sci 2010; 25: 333-5.
4. Aronowitz J, Safferman A, Lieberman J. Management of clozapine-induced enuresis. Am J Psychiatry 1995; 152: 472.
5. Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994; 9: 207-9. (Pubitemid 24317185)
6. Agarwal V. Urinary incontinence with risperidone. J Clin Psychiatry 2000; 61: 219.
7. Kantrowitz JT, Srihari VH, Tek C. Three cases of risperidone-induced enuresis. Schizophr Res 2006; 84: 174-5.
8. Vernon LT, Fuller MA, Hattab H, Varnes KM. Olanzapine-induced urinary incontinence: treatment with ephedrine. J Clin Psychiatry 2000; 61: 601-2.
9. Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, et al. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol 2007; 22: 238-43. (Pubitemid 46801948)
10. Harrison-Woolrych M, Coulter DM. PEM in New Zealand. In Pharmacovigilance (eds R Mann, E Andrews): 317-32. John Wiley & Sons, 2007.
11. Edwards I, Biriell C. WHO Programme - global monitoring. In Pharmacovigilance (eds R Mann, E Andrews): 151-66. John Wiley & Sons, 2002.
12. Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975; 234: 1236-41.
13. Hirasing RA, van Leerdam FJM, Bolk-Bennink L, Janknegt RA. Enuresis nocturna in adults. Scand J Urol Nephrol 1997; 31: 533-6. (Pubitemid 28020561)
14. Centorrino F, Baldessarini RJ, Kando JC, Frankenburg FR, Volpicelli SA, Flood JG. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol 1994; 14: 119-25. (Pubitemid 24120710)
15. Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry 1996; 57: 514-8. (Pubitemid 26412502)
16. Thornicroft G, Tansella M. Components of a modern mental health service: a pragmatic balance of community and hospital care. Overview of systematic evidence. Br J Psychiatry 2004; 185: 283-90. (Pubitemid 39331329)
17. Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, et al. Effectiveness of olanzapine, quetiapine, risperidone and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry 2006; 163: 611-22. (Pubitemid 44464570)
18. Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, DeThomas C, Kafantaris V, et al. Clozapine and 'high-dose' olanzapine in refractory early-onset schizophrenia: a 12 week randomized and double-blind comparison. Biol Psychiatry 2008; 63: 524-9. (Pubitemid 351220784)
19. Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 2009; 35: 443-57.
20. Kho KH, Nielsen O. Clozapine-induced nocturnal enuresis: diagnostic and treatment issues. Psychiatr Bull 2001; 25: 232-3. (Pubitemid 32544782)
21. Vera PL, Nadelhaft I. Clozapine inhibits micturition parameters and the external urethral sphincter during cystometry in anaesthetized rats. Brain Res 2001; 901: 219-29. (Pubitemid 32718825)
22. Vera PL, Miranda-Sousa A, Nadelhaft I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anaesthetized rats. BMC Pharmacol 2001; 1: 4.
23. Bendz H, Aurell M. Drug-induced diabetes insipidus. Drug Saf 1999; 21: 449-56.
24. Etienne L, Wittebole X, Liolios A, Hantson P. Polyuria after olanzapine overdose. Am J Psychiatry 2004; 161: 1130.
25. Safferman A, Lieberman JA, Kane JM, Szymanski S, Kinon B. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991; 17: 247-61.